179 related articles for article (PubMed ID: 34575445)
1. Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System.
Rodolfo C; Eusébio D; Ventura C; Nunes R; Florindo HF; Costa D; Sousa Â
Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575445
[TBL] [Abstract][Full Text] [Related]
2. Optimization of peptide-plasmid DNA vectors formulation for gene delivery in cancer therapy exploring design of experiments.
Sousa Â; Almeida AM; Faria R; Konate K; Boisguerin P; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2019 Nov; 183():110417. PubMed ID: 31408780
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Chitosan-TPP Nanoparticle Properties for Plasmid DNA Vaccines Delivery.
Nunes R; Serra AS; Simaite A; Sousa Â
Polymers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406316
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
5. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics.
Bozkir A; Saka OM
Drug Deliv; 2004; 11(2):107-12. PubMed ID: 15200009
[TBL] [Abstract][Full Text] [Related]
6. Targeted DNA delivery to cancer cells using a biotinylated chitosan carrier.
Darvishi MH; Nomani A; Hashemzadeh H; Amini M; Shokrgozar MA; Dinarvand R
Biotechnol Appl Biochem; 2017 May; 64(3):423-432. PubMed ID: 27037851
[TBL] [Abstract][Full Text] [Related]
7. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system.
Akrami-Hasan-Kohal M; Eskandari M; Solouk A
Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells.
Malakooty Poor E; Baghaban Eslaminejad M; Gheibi N; Bagheri F; Atyabi F
Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):376-84. PubMed ID: 24001051
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity and transfection efficiency of pDNA encoded p53 gene-loaded chitosan-sodium deoxycholate nanoparticles.
Hashem FM; Nasr M; Khairy A; Alqurshi A
Int J Nanomedicine; 2019; 14():4123-4131. PubMed ID: 31239671
[No Abstract] [Full Text] [Related]
10. Characterization of pDNA-TMC Nanoparticle Interaction and Stability.
Poecheim J; Patrulea V; Reichert C; Borchard G
Curr Drug Deliv; 2016; 13(3):301-8. PubMed ID: 26638979
[TBL] [Abstract][Full Text] [Related]
11. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells.
Hallaj-Nezhadi S; Valizadeh H; Dastmalchi S; Baradaran B; Jalali MB; Dobakhti F; Lotfipour F
J Pharm Pharm Sci; 2011; 14(2):181-95. PubMed ID: 21733408
[TBL] [Abstract][Full Text] [Related]
12. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
13. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study.
Karimi M; Avci P; Ahi M; Gazori T; Hamblin MR; Naderi-Manesh H
J Nanopharm Drug Deliv; 2013 Sep; 1(3):266-278. PubMed ID: 26989641
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antibacterial activity of uniform and stable chitosan nanoparticles containing metronidazole against anaerobic bacterium of Bacteroides fragilis.
Binesh N; Farhadian N; Mohammadzadeh A
Colloids Surf B Biointerfaces; 2021 Jun; 202():111691. PubMed ID: 33743445
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
18. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
Tian J; Yu J; Sun X
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):220-9. PubMed ID: 18722672
[TBL] [Abstract][Full Text] [Related]
19. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
Martien R; Loretz B; Schnürch AB
Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
[TBL] [Abstract][Full Text] [Related]
20. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
